Ads
related to: takeda pharmaceuticals products- Dosing & Titration
Get Appropriate Dosing
for Patients. Learn More.
- Patient Brochure
Get Resources for Patients
Interested in this T2D Treatment
- Clinical Trial Results
Understand Clinical Trial Data
& Findings. Learn More on Site.
- Co-Pay Card
Cost Savings for Eligible Patients.
Learn More.
- Dosing & Titration
Search results
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 1 month agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript May 11, 2023...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 3 weeks agoHEALTH Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit...
One Ultra-Cheap High-Yield Dividend Stock to Buy
Motley Fool via Yahoo Finance· 5 months agoDividend stocks that trade at cheap valuations can give investors multiple ways to profit from them. In addition to dividend income, you're also...
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
Motley Fool· 9 months agoIf you're looking for a high-yield dividend stock in the healthcare sector, you might be interested...
Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
Reuters via Yahoo Finance· 10 months agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical posted first-quarter profit that beat analysts'...
Japan's Takeda slashes full-year profit forecast on drug pipeline impairments
Reuters via Yahoo News· 7 months agoTOKYO (Reuters) -Japan's biggest drugmaker Takeda Pharmaceutical on Thursday slashed its full-year...
New Strong Buy Stocks for April 25th
Zacks via Yahoo Finance· 1 month agoHere are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Takeda Pharmaceutical Company Limited TAK: This company that engages in the...
Takeda pays $300M to license Protagonist drug for blood disorder
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Protagonist Therapeutics, a biotechnology company focused on peptide drugs, is teaming...
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 3 weeks agoCatalyst Pharmaceuticals' new Chief Executive, Richard Daly, is no stranger to working at big...
